Iodine loaded nanoparticles with commercial applicability increase survival in mice cancer models with low degree of side effects
Abstract Background The recorded use of iodine in medicine, dates to 5000 BC. Molecular iodine (I2) has been claimed to exert an antineoplastic effect that triggers apoptotic and re‐differentiation mechanisms in different types of cancer cells in animal studies. Hitherto, all experiments published h...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1843 |